Romanel, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 8.442
AS - Asia 2.835
EU - Europa 2.348
SA - Sud America 504
Continente sconosciuto - Info sul continente non disponibili 268
AF - Africa 59
OC - Oceania 11
Totale 14.467
Nazione #
US - Stati Uniti d'America 8.248
SG - Singapore 1.052
VN - Vietnam 677
IT - Italia 603
CN - Cina 478
BR - Brasile 391
RU - Federazione Russa 387
DE - Germania 306
FI - Finlandia 200
SE - Svezia 155
GB - Regno Unito 143
CA - Canada 124
HK - Hong Kong 116
FR - Francia 115
UA - Ucraina 95
KR - Corea 92
LV - Lettonia 89
IN - India 82
ID - Indonesia 69
BD - Bangladesh 64
NL - Olanda 52
AR - Argentina 45
JP - Giappone 41
BG - Bulgaria 31
ES - Italia 28
IQ - Iraq 28
JO - Giordania 25
PL - Polonia 25
AT - Austria 24
MX - Messico 21
CO - Colombia 20
LT - Lituania 20
ZA - Sudafrica 20
EC - Ecuador 17
CZ - Repubblica Ceca 15
PK - Pakistan 15
IE - Irlanda 13
CR - Costa Rica 11
TR - Turchia 11
TH - Thailandia 10
UZ - Uzbekistan 10
CL - Cile 9
DZ - Algeria 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
MA - Marocco 8
AU - Australia 7
PY - Paraguay 7
HN - Honduras 6
JM - Giamaica 6
LB - Libano 6
VE - Venezuela 6
NO - Norvegia 5
PH - Filippine 5
PR - Porto Rico 5
RO - Romania 5
SA - Arabia Saudita 5
BE - Belgio 4
NZ - Nuova Zelanda 4
AL - Albania 3
BB - Barbados 3
EG - Egitto 3
GT - Guatemala 3
HR - Croazia 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GP - Guadalupe 2
GR - Grecia 2
GY - Guiana 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
Totale 14.178
Città #
Ashburn 960
Fairfield 734
Singapore 660
Chandler 530
San Jose 457
Woodbridge 334
Seattle 302
Dallas 273
Houston 260
Santa Clara 250
Cambridge 228
Wilmington 221
Columbus 214
Council Bluffs 200
Ho Chi Minh City 191
Jacksonville 186
Hanoi 165
Munich 158
Los Angeles 155
Trento 155
Moscow 153
San Mateo 148
Ann Arbor 142
New York 134
Helsinki 123
Princeton 112
The Dalles 103
Hong Kong 95
Beijing 90
Riga 89
Seoul 81
Phoenix 75
Lauterbourg 68
Boardman 64
Buffalo 60
St Louis 55
Jakarta 52
Orem 50
Chicago 49
Como 49
London 43
Da Nang 41
Dong Ket 40
Milan 40
San Diego 38
São Paulo 38
Montreal 34
Dearborn 33
Tokyo 33
Rome 32
Hefei 31
Sofia 30
Frankfurt am Main 29
Brooklyn 26
Bremen 24
Redondo Beach 23
Toronto 23
Salt Lake City 22
Denver 21
Haiphong 21
Warsaw 21
Atlanta 20
Nuremberg 20
North Bergen 19
Chennai 18
Lappeenranta 18
Shanghai 18
Washington 18
Amsterdam 17
San Francisco 17
San Paolo di Civitate 17
Tolentino 17
Turku 17
Johannesburg 16
Guangzhou 15
Rio de Janeiro 15
Lawrence 14
Manchester 14
Biên Hòa 13
Boston 13
Verona 13
Vienna 13
Mumbai 12
Ottawa 12
Thái Bình 12
Vilnius 12
Brno 11
Newark 11
Philadelphia 11
Stockholm 11
Baghdad 10
Falkenstein 10
Riverside 10
Salvador 10
Tampa 10
Andover 9
Belo Horizonte 9
Bogotá 9
Bến Tre 9
Changsha 9
Totale 9.597
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 388
A highly specific SpCas9 variant is identified by in vivo screening in yeast 361
Inherited determinants of early recurrent somatic mutations in prostate cancer 352
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 286
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 266
ASEQ: Fast allele-specific studies from next-generation sequencing data 256
Polympact: Exploring functional relations among common human genetic variants 251
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 240
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer 239
EthSEQ: ethnicity annotation from whole exome sequencing data 238
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 226
Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma 224
Ancestry-specific predisposing germline variants in cancer 220
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA 215
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 211
TRPM8 levels determine tumor vulnerability to channel agonists. 207
Estimating the divisibility of complex biological networks by sparseness indices 202
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 194
Programming Biology in BlenX 192
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 192
A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness 190
The Decidability of the Structural Congruence for Beta-binders 189
Modelling self-assembly in BlenX 189
Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations 186
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 184
Exploring functionally annotated transcriptional consensus regulatory elements with CONREL 184
In-silico identification and functional validation of allele-dependent AR enhancers 181
One-shot analysis of translated mammalian lncrnas with aharibo 181
Modelling and simulation of biological processes in BlenX 177
The Beta Workbench: a computational tool to study the dynamics of biological systems 176
Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence 175
A Formal and Integrated Framework to Simulate Evolution of Biological Pathways 174
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 174
Analytical protocol to identify local ancestry-associated molecular features in cancer 170
Transcriptional regulation is a major controller of cell cycle transition dynamics 168
Germline determinants of aberrant signaling pathways in cancer 168
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 167
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay 167
Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster 163
Exploiting non-Markovian Bio-Processes 159
Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer 158
Plasma AR and abiraterone-resistant prostate cancer 153
BlenX Static and Dynamic Semantics 153
Punctuated evolution of prostate cancer genomes. 152
Modeling Static Biological Compartments with Beta-binders 152
A Formal and Integrated Framework to Simulate Evolution of Biological Pathways 151
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice 146
Evolving BlenX programs to simulate the evolution of biological networks 146
Effective Index: A Formal Measure of Drug Effects 145
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 145
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 145
Tumor clone dynamics in lethal prostate cancer 144
TranSNPs: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance 140
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes 139
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care 138
Unraveling the clonal hierarchy of somatic genomic aberrations 137
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer 135
On the Decidability and Complexity of the Structural Congruence for Beta-binders 134
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 134
The three YTHDF paralogs and VIRMA are strong cross-histotype tumor driver candidates among m6A core genes 130
Simple methods for peak and valley detection in time series microrray data 130
Inherited variant in NFκB‐1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding 130
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer 126
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 125
Simple methods for peak and valley detection in time series microarray data 121
BetaWB: modelling and simulating biological processes 120
Allele-specific expression analysis in cancer using next-generation sequencing data 119
Dynamic Biological Modelling: a language-based approach 118
On the Computational Power of BlenX 117
The BlenX Language: A Tutorial 116
SpikeFlow: automated and flexible analysis of ChIP-Seq data with spike-in control 114
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers 114
On the impact of discreteness and abstractions on modelling noise in gene regulatory networks 112
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response 110
Self-assembly processes with cooperativity 106
Analysis of Genetic Ancestry from NGS Data Using EthSEQ 103
Towards a process calculi approach to study the evolution of biological networks 101
Analysis of germline-driven ancestry-associated gene expression in cancers 98
The BlenX Language: A Tutorial 97
The Beta Workbench 95
Beta-binders with Static Compartments 94
Effective Index: A Formal Measure of Drug Effects 91
Synggen: fast and data-driven generation of synthetic heterogeneous NGS cancer data 89
On the Decidability and Complexity of the Structural Congruence for Beta-binders 85
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 74
On the Computational Power of BlenX 68
Simulation of non-Markovian Processes in BlenX 65
Integrative Computational Analysis of Common EXO5 Haplotypes: Impact on Protein Dynamics, Genome Stability, and Cancer Progression 64
CLISGen: A Comprehensive Resource of SNP Genotypes for Human Cell Lines 59
HapScoreDB: a database of protein language model functional scores for haplotype-resolved protein sequences 45
Polysomal Profiling Coupled to Allele-Specific Proteomics Reveals an EIF4H TranSNP Allele Possessing Higher mRNA Translation Potential 32
GenoEye: A machine learning-based framework for the prediction of intermediate eye color phenotypes 27
Patient-specific modeling of G2/M cell cycle dynamics reveals prognostic dynamical regimes driven by copy number alterations 22
Decoding neuronal vulnerability: Multidimensional analysis of D1R‐ and D2R‐ medium‐sized spiny neurons in Huntington's disease 21
Totale 14.467
Categoria #
all - tutte 56.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.976
Totale 59.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022717 0 0 0 42 31 34 17 178 60 90 92 173
2022/20231.072 157 155 14 186 87 148 10 86 122 15 53 39
2023/2024560 25 34 34 11 58 154 33 56 23 38 10 84
2024/20252.326 26 20 176 419 104 272 144 119 235 410 162 239
2025/20265.073 383 138 597 665 464 296 1.014 119 413 458 365 161
2026/20271.664 113 205 626 720 0 0 0 0 0 0 0 0
Totale 14.467